High degree of interlaboratory reproducibility of human immunodeficiency virus type 1 protease and reverse transcriptase sequencing of plasma samples from heavily treated patients

被引:52
|
作者
Shafer, RW
Hertogs, K
Zolopa, AR
Warford, A
Bloor, S
Betts, BJ
Merigan, TC
Harrigan, R
Larder, BA
机构
[1] Stanford Univ, Med Ctr, Div Infect Dis, Stanford, CA 94305 USA
[2] Stanford Univ, Med Ctr, AIDS Res Ctr, Stanford, CA 94305 USA
[3] Stanford Univ Hosp, Diagnost Virol Lab, Stanford, CA 94305 USA
[4] Stanford Univ Hosp, Dept Biostat, Stanford, CA 94305 USA
[5] VIRCO Belgium, Cent Virol Lab, Mechelen, Belgium
[6] VIRCO UK, Cambridge CB4 4GH, England
关键词
D O I
10.1128/JCM.39.4.1522-1529.2001
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We assessed the reproducibility of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) and protease sequencing using cryopreserved plasma aliquots obtained from 36 heavily treated HIV-1-infected individuals in two laboratories using: dideoxynucleotide sequencing. The rates of complete sequence concordance between the two laboratories were 99.1% for the protease sequence and 99.0% for the RT sequence. Approximately 90% of the discordances were partial, defined as one laboratory detecting a mixture and the second laboratory detecting only one of the mixture's components. Only 0.1% of the nucleotides were completely discordant between the two laboratories, and these were significantly more likely to occur in plasma samples with lower plasma HIV-I RNA levels, Nucleotide mixtures were detected at approximately 1% of the nucleotide positions, and in every case in which one laboratory detected a mixture, the second laboratory either detected the same mixture or detected one of the mixture's components. The high rate of concordance in detecting mixtures and the fact that most discordances between the two laboratories were partial suggest that most discordances were caused by variation in sampling of the HIV-1 quasispecies by PCR rather than by technical errors in the sequencing process itself.
引用
收藏
页码:1522 / 1529
页数:8
相关论文
共 50 条
  • [1] Reproducibility of human immunodeficiency virus type 1 (HIV-1) protease and reverse transcriptase sequencing of plasma samples from heavily treated HIV-1-infected individuals
    Shafer, RW
    Warford, A
    Winters, MA
    Gonzales, MJ
    JOURNAL OF VIROLOGICAL METHODS, 2000, 86 (02) : 143 - 153
  • [2] Antiretroviral resistance mutations in human immunodeficiency virus type 1 reverse transcriptase and protease from paired cerebrospinal fluid and plasma samples
    Venturi, G
    Catucci, M
    Romano, L
    Corsi, P
    Leoncini, F
    Valensin, PE
    Zazzi, M
    JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (02): : 740 - 745
  • [3] Human immunodeficiency virus type 1 reverse transcriptase
    Hottiger, M
    Hubscher, U
    BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 1996, 377 (02): : 97 - 120
  • [4] Mutations in the Reverse Transcriptase and Protease Genes of Human Immunodeficiency Virus-1 from Antiretroviral Naive and Treated Pediatric Patients
    Bure, Dinesh
    Makhdoomi, Muzamil A.
    Lodha, Rakesh
    Prakash, Somi Sankaran
    Kumar, Rajesh
    Parray, Hilal A.
    Singh, Ravinder
    Kabra, Sushil K.
    Luthra, Kalpana
    VIRUSES-BASEL, 2015, 7 (02): : 590 - 603
  • [5] Intra patient evolution of Human Immunodeficiency Virus Type 1 protease and reverse transcriptase in antiretroviral naive patients
    Shanmugasundaram, Uma
    Nagalingeswaran, Kumarasamy
    Murugavel, Kailapuri G.
    Shanmugam, Saravanan
    Madhavan, Vidya
    Solomon, Sunil S.
    Solomon, Suniti
    Mayer, Kenneth H.
    Pachamuthu, Balakrishnan
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2009, 51 : 185 - 185
  • [6] Comparison of sequencing by hybridization and cycle sequencing for genotyping of human immunodeficiency virus type 1 reverse transcriptase
    Hanna, GJ
    Johnson, VA
    Kuritzkes, DR
    Richman, DD
    Martinez-Picado, J
    Sutton, L
    Hazelwood, JD
    D'Aquila, RT
    JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (07) : 2715 - 2721
  • [7] Substitution of a nonnucleoside reverse transcriptase inhibitor for a protease inhibitor in the treatment of patients with undetectable plasma human immunodeficiency virus type 1 RNA
    Raffi, F
    Bonnet, B
    Ferré, V
    Esnault, JL
    Perré, P
    Reliquet, V
    Leautez, S
    Bouillant, C
    Vergnoux, O
    Weinbreck, P
    CLINICAL INFECTIOUS DISEASES, 2000, 31 (05) : 1274 - 1278
  • [8] Human immunodeficiency virus type 1 reverse transcriptase and protease mutation search engine for queries
    Robert W. Shafer
    Duane R. Jung
    Bradley J. Betts
    Nature Medicine, 2000, 6 : 1290 - 1292
  • [9] Human immunodeficiency virus type 1 reverse transcriptase and protease mutation search engine for queries
    Shafer, RW
    Jung, DR
    Betts, BJ
    NATURE MEDICINE, 2000, 6 (11) : 1290 - 1292
  • [10] Resistance of human immunodeficiency virus type 1 to reverse transcriptase and protease inhibitors:: genotypic and phenotypic testing
    García-Lerma, JG
    Heneine, W
    JOURNAL OF CLINICAL VIROLOGY, 2001, 21 (03) : 197 - 212